Qbrexza™ (glycopyrronium) – New drug approval
June 29, 2018 - Dermira announced the FDA approval of Qbrexza (glycopyrronium) for topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
Download PDF
